Compounds > platinum
Page last updated: 2024-08-22

platinum and Malignant Mesothelioma

platinum has been researched along with Malignant Mesothelioma in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (40.00)24.3611
2020's12 (60.00)2.80

Authors

AuthorsStudies
Danese, MD; Daumont, M; Gleeson, M; Lubeck, D; Nwokeji, E; Penrod, JR1
Duan, J; Jiang, Z; Zeng, X1
Asghari, AB; Chai, SM; Creaney, J; Dick, IM; Firth, T; Hansen, J; Lee, YCG; Louw, A; Lynggaard, LA; Meristoudis, C; Panou, V; Røe, OD; Szejniuk, WM; van Vliet, C; Vyberg, M1
Ma, J; Zhang, S1
Dunne, B; Harden, S; Hoang, W; John, T; Leal, JL; Xue, J1
Cengel, K; Ciunci, C; Karakousis, G; Katz, S; Langer, CJ; Marmarelis, ME; McNulty, S; Miura, J; Roshkovan, L; Walker, S; Wang, X1
Belletti, M; Bono, F; Bonomi, M; Canova, S; Carlucci, L; Ceresoli, GL; Cortinovis, DL; D'Aveni, A; De Angelis, A; De Simone, I; Galli, F; Gelsomino, F; Grosso, F; Mencoboni, M; Pasello, G; Perrino, M; Rulli, E; Zucali, PA1
Abo Elkasem, F; Bahnassy, A; Gaafer, R; Khorshid, O; Wahba, NI1
Barbier, MC; Bhadhuri, A; Fengler, A; Gautschi, O; Meier, N; Pardo, E1
Cedrés, S; Hansen, TB; Herrera-Juarez, M; Isambert, N; Jaderberg, M; Lederlin, M; Levitsky, V; Martinez-Marti, A; Navarro, A; Paz-Ares, L; Ponce, S; Ricordel, C; Serres, X; Vetrhus, S; Viteri, S; Zugazagoitia, J1
Ilonen, I; Järvinen, T; Koli, K; Lauri, H; Lemström, K; Myllärniemi, M; Ollila, H; Paajanen, J; Räsänen, J; Ritvos, O; Rouvinen, E; Sutinen, E1
Doi, H; Ishigaki, H; Kijima, T; Kitajima, K; Koda, Y; Kuribayashi, K; Minami, T; Nakajima, Y; Nakamura, A; Takahashi, R; Yokoi, T1
Bonta, M; Holzlechner, M; Limbeck, A; Lohninger, H; Marchetti-Deschmann, M1
Ardito, R; Barni, S; Borgonovo, K; Cabiddu, M; Coinu, A; Conti, B; Ghidini, A; Ghilardi, M; Petrelli, F1
Archila, P; Arrieta, O; Bacon, L; Báez, R; Campos Gómez, S; Cardona, AF; Carranza, H; Chirinos, L; Corrales, L; Cuello, M; de Lima, VCC; Freitas, HC; González, L; Granados, ST; Karachaliou, N; Martín, C; Mas, L; Núñez Cerrillo, G; Oblitas, G; Otero, J; Pérez, MA; Ramírez-Tirado, LA; Remolina Bonilla, YA; Rodriguez, J; Rojas, L; Rosell, R; Ruiz-Patiño, A; Trejo-Rosales, R; Vargas, C; Zatarain-Barrón, ZL1
Aasheim, LB; Abrahamsen, TW; Davidson, B; Dybdahl, B; Flatmark, K; Fromm, B; Hovig, E; Julsrud, L; Kristensen, AT; Larsen, SG; Lund-Andersen, C; Nakken, S; Nygård, S1
Alewine, C; Calzone, K; Churpek, JE; Desai, A; Gadiraju, M; Gao, S; Gulsuner, S; Hassan, R; Hesdorffer, M; Khan, J; Kindler, HL; King, MC; Lee, MK; Mian, I; Morrow, B; Padiernos, E; Panou, V; Patel, S; Raffeld, M; Schrump, DS; Steinberg, SM; Thomas, A; Walsh, T; Wei, JS; Xi, L; Zhang, J1
Akca, Z; Aksahin, A; Aslan, T; Berk, V; Buyukcelik, A; Erden, A; Karaca, H; Mutlu, H; Ozkan, M1
Kang, YM; Lin, DJ; Liu, QH; Tian, GY; Wan, YY; Yang, SX; Yao, F; Yao, ZH1
Felley-Bosco, E; Friess, M; Frischknecht, L; Korol, D; Opitz, I; Soltermann, A; Stahel, R; Thies, S; Vrugt, B; Weder, W1

Reviews

1 review(s) available for platinum and Malignant Mesothelioma

ArticleYear
A systematic review and meta-analysis of second-line therapies for treatment of mesothelioma.
    Respiratory medicine, 2018, Volume: 141

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Platinum; Progression-Free Survival; Treatment Outcome

2018

Trials

2 trial(s) available for platinum and Malignant Mesothelioma

ArticleYear
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma.
    ESMO open, 2022, Volume: 7, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Platinum; Pleural Neoplasms

2022
ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment.
    Journal for immunotherapy of cancer, 2023, Volume: 11, Issue:9

    Topics: Carboplatin; Cisplatin; Humans; Mesothelioma, Malignant; Pemetrexed; Platinum; Tumor Microenvironment

2023

Other Studies

17 other study(ies) available for platinum and Malignant Mesothelioma

ArticleYear
Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results-Medicare data.
    Cancer reports (Hoboken, N.J.), 2022, Volume: 5, Issue:9

    Topics: Aged; Female; Humans; Male; Medicare; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Platinum; Pleural Neoplasms; Retrospective Studies; United States

2022
[Analysis of the Efficacy of Pemetrexed Maintenance Therapy in Patients with 
Malignant Pleural Mesothelioma].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2022, Jan-20, Volume: 25, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Neutropenia; Pemetrexed; Platinum; Pleural Neoplasms

2022
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2022, Volume: 17, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Humans; Immunohistochemistry; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Platinum; Pleural Neoplasms; Tumor Suppressor Proteins; Ubiquitin Thiolesterase

2022
Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients.
    World journal of surgical oncology, 2022, Jun-29, Volume: 20, Issue:1

    Topics: Female; Humans; Ki-67 Antigen; Mesothelioma, Malignant; Paclitaxel; Pemetrexed; Peritoneal Neoplasms; Platinum; Prognosis; Retrospective Studies

2022
What's Current and What's New in Mesothelioma?
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2022, Volume: 34, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Platinum; Pleural Neoplasms

2022
A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma.
    PloS one, 2022, Volume: 17, Issue:9

    Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Humans; Mesothelioma, Malignant; Middle Aged; Peritoneal Neoplasms; Peritoneum; Platinum; Retrospective Studies

2022
The Predictive Value of ERCC1, RRM1, and Thymidylate Synthase in Advanced Malignant Pleural Mesothelioma Patients Treated with Platinum-Based Chemotherapy.
    Asian Pacific journal of cancer prevention : APJCP, 2023, Jan-01, Volume: 24, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Endonucleases; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Platinum; Prospective Studies; Thymidylate Synthase; Treatment Outcome

2023
Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland.
    PharmacoEconomics, 2023, Volume: 41, Issue:12

    Topics: Bevacizumab; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Humans; Ipilimumab; Mesothelioma, Malignant; Nivolumab; Pemetrexed; Platinum; Switzerland

2023
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy.
    Clinical lung cancer, 2020, Volume: 21, Issue:3

    Topics: Activins; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cachexia; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mesothelioma, Malignant; Middle Aged; Platinum; Pleural Neoplasms; Prognosis; Prospective Studies; Retrospective Studies; ROC Curve

2020
Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study.
    Oncology, 2021, Volume: 99, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Irinotecan; Japan; Kaplan-Meier Estimate; Leukopenia; Male; Mesothelioma, Malignant; Middle Aged; Neutropenia; Pemetrexed; Platinum; Progression-Free Survival; Retrospective Studies; Thrombocytopenia

2021
Multisensor Imaging-From Sample Preparation to Integrated Multimodal Interpretation of LA-ICPMS and MALDI MS Imaging Data.
    Analytical chemistry, 2018, 08-07, Volume: 90, Issue:15

    Topics: Antineoplastic Agents; Cisplatin; Elements; Humans; Laser Therapy; Lipids; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Molecular Imaging; Multimodal Imaging; Multivariate Analysis; Phosphorus; Platinum; Pleura; Specimen Handling; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry

2018
Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP).
    Thoracic cancer, 2019, Volume: 10, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Latin America; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Platinum; Pleural Neoplasms; Progression-Free Survival; Thoracic Surgical Procedures

2019
Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response.
    Cold Spring Harbor molecular case studies, 2019, Volume: 5, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genetic Variation; Genomics; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Palliative Care; Pemetrexed; Peritoneal Neoplasms; Platinum; Treatment Outcome; Young Adult

2019
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 04-30, Volume: 116, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; DNA Repair; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Platinum; Pleural Neoplasms; Survival Analysis; Tumor Suppressor Proteins; Ubiquitin Thiolesterase; Young Adult

2019
Secondline chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: a retrospective study.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Staging; Palliative Care; Pemetrexed; Platinum; Pleural Neoplasms; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate

2013
Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Pharmacological; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Platinum; Pleural Neoplasms; Prognosis; Proportional Hazards Models; Serum Albumin

2014
Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Cell Adhesion Molecules; Cell Line, Tumor; Chemotherapy, Adjuvant; Cohort Studies; Deoxycytidine; Disease-Free Survival; Epithelial-Mesenchymal Transition; Female; Gemcitabine; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Nestin; Pemetrexed; Platinum; Pleural Neoplasms; Pneumonectomy; Prognosis; Sarcoma; Stem Cell Factor

2015